Literature DB >> 15238352

Acute regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules.

S Soodvilai1, V Chatsudthipong, K K Evans, S H Wright, W H Dantzler.   

Abstract

We investigated the regulation of organic anion transport driven by the organic anion transporter 3 (OAT3), a multispecific OAT localized at the basolateral membrane of the renal proximal tubule. PMA, a PKC activator, inhibited uptake of estrone sulfate (ES), a prototypic substrate for OAT3, in a dose- and time-dependent manner. This inhibition was reduced by 100 nM bisindoylmaleimide I (BIM), a specific PKC inhibitor. The alpha(1)-adrenergic receptor agonist phenylephrine also inhibited ES uptake, and this effect was reduced by BIM. These results suggest that PKC activation downregulates OAT3-mediated organic anion transport. In contrast, epidermal growth factor (EGF) increased ES uptake following activation of MAPK. Exposure to PGE(2) or dibutyryl (db)-cAMP also enhanced ES uptake. Stimulation produced by PGE(2) and db-cAMP was prevented by the PKA inhibitor H-89, indicating that this stimulation required PKA activation. In addition, inhibition of cyclooxygenase 1 (COX1) (but not COX2) inhibited ES uptake. Furthermore, the stimulatory effect of EGF was eliminated by inhibition of either COX1 or PKA. These data suggest that EGF stimulates ES uptake by a process in which MAPK activation results in increased PGE(2) production that, in turn, activates PKA and subsequently stimulates ES uptake. Interestingly, EGF did not induce upregulation immediately following phenylephrine-induced downregulation; and phenylephrine did not induce downregulation immediately after EGF-induced upregulation. These data are the first to show the regulatory response of organic anion transport driven by OAT3 in intact renal proximal tubules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15238352     DOI: 10.1152/ajprenal.00080.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  17 in total

1.  Decreased blood-brain barrier permeability to fluorescein in streptozotocin-treated rats.

Authors:  Brian T Hawkins; Scott M Ocheltree; Kristi M Norwood; Richard D Egleton
Journal:  Neurosci Lett       Date:  2006-11-15       Impact factor: 3.046

Review 2.  Physiology, structure, and regulation of the cloned organic anion transporters.

Authors:  C Srimaroeng; J L Perry; J B Pritchard
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

3.  Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis.

Authors:  Yuji Sakurai; Hideyuki Motohashi; Ken Ogasawara; Tomohiro Terada; Satohiro Masuda; Toshiya Katsura; Noriko Mori; Motokazu Matsuura; Toshio Doi; Atsushi Fukatsu; Ken-ichi Inui
Journal:  Pharm Res       Date:  2005-11-01       Impact factor: 4.200

4.  Expression of organic anion transporters 1 and 3 in the ovine fetal brain during the latter half of gestation.

Authors:  Roderick Cousins; Charles E Wood
Journal:  Neurosci Lett       Date:  2010-08-11       Impact factor: 3.046

Review 5.  Molecular insights into the structure-function relationship of organic anion transporters OATs.

Authors:  Fanfan Zhou; Guofeng You
Journal:  Pharm Res       Date:  2006-11-14       Impact factor: 4.200

6.  Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis.

Authors:  Mark J Canet; Rhiannon N Hardwick; April D Lake; Anika L Dzierlenga; John D Clarke; Michael J Goedken; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2014-12-08       Impact factor: 3.922

7.  Exhaustive exercise decreases renal organic anion transporter 3 function.

Authors:  Tipwadee Bunprajun; Chaowalit Yuajit; Rattikarn Noitem; Varanuj Chatsudthipong
Journal:  J Physiol Sci       Date:  2018-10-03       Impact factor: 2.781

8.  Regulation of renal organic anion transporter 3 (SLC22A8) expression and function by the integrity of lipid raft domains and their associated cytoskeleton.

Authors:  Chutima Srimaroeng; Jennifer Perry Cecile; Ramsey Walden; John B Pritchard
Journal:  Cell Physiol Biochem       Date:  2013-04-26

9.  The concomitant use of meloxicam and methotrexate does not clearly increase the risk of silent kidney and liver damages in patients with rheumatoid arthritis.

Authors:  Hee-Jin Park; Min-Chan Park; Yong-Beom Park; Soo-Kon Lee; Sang-Won Lee
Journal:  Rheumatol Int       Date:  2013-12-22       Impact factor: 2.631

10.  Short-term regulation of the Cl-/HCO3(-) exchanger in immortalized SHR proximal tubular epithelial cells.

Authors:  Sónia Simão; Rui Pedrosa; Ulrich Hopfer; David B Mount; Pedro A Jose; Patrício Soares-da-Silva
Journal:  Biochem Pharmacol       Date:  2008-03-15       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.